GLOW

What is GLOW

GLOW is a three-peptide research blend that pairs GHK-Cu (50mg), BPC-157 (10mg) and TB-500 (10mg) in a single lyophilized vial, 70mg total. The idea is to combine a regenerative copper-binding peptide with two of the most studied healing peptides in tissue biology, so researchers can study three complementary signals together instead of mixing three separate vials.

GHK-Cu is the copper-bound form of the natural human tripeptide GHK. It is best known in skin and wound-healing research. BPC-157 is a 15 amino acid sequence isolated from gastric juice protein BPGP, studied for tendon, muscle, ligament and gut regeneration. TB-500 is the active 17 amino acid fragment of Thymosin Beta-4, an actin-binding protein with established roles in cell migration, angiogenesis and tissue remodeling.

We supply GLOW as a freeze-dried powder, ready for reconstitution and use in laboratory protocols.

How it works

The three peptides act on complementary pathways.

GHK-Cu delivers copper exactly where cells need it. Copper is the cofactor for enzymes that build collagen cross-links and run antioxidant defense. On top of that, the GHK part of the molecule behaves like a switch that nudges thousands of genes toward a more regenerative profile in laboratory experiments. Studies show GHK-Cu boosts collagen production, helps form new capillaries, activates fibroblasts and reduces oxidative-stress markers in cell and animal work.

BPC-157 is the build-and-stabilize signal. In published research it upregulates growth-hormone receptor expression, modulates VEGF-driven angiogenesis and accelerates tendon, muscle and gastric ulcer healing in rodent models. Unlike most peptides, it remains stable in gastric juice, which is why oral and topical formulations have been examined alongside injectable routes.

TB-500 acts on the cytoskeleton. By binding monomeric G-actin it controls how fibroblasts, endothelial cells and progenitor cells migrate into a wound site. Research links it to faster wound closure, reduced fibrosis and capillary regrowth in cardiac, corneal and skin models.

In a blend, the three peptides cover the matrix-building side (GHK-Cu), the systemic repair side (BPC-157) and the cell-migration side (TB-500) of tissue research at the same time.

Often studied alongside

A common four-peptide extension of this blend adds KPV, the anti-inflammatory C-terminal tripeptide of alpha-MSH, for an additional layer of anti-inflammatory signaling. It is sold as KLOW in research catalogs.

The individual components are also available on their own for studies that need single-peptide controls.

For reconstitution, the standard solvent in published protocols is bacteriostatic or sterile water. The dissolved blend takes on a faint blue tint from the copper complex in GHK-Cu.

Documentation